Superconductor technologies inc (SCON)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Total revenues

545

1,556

446

131

-

-

-

-

-

-

-

Commercial product revenues

-

-

-

-

244

-

-

-

-

-

-

Net commercial product revenues

-

-

-

-

-

-

1,710

3,237

3,416

6,548

7,239

Government contract revenues

-

-

-

-

-

-

-

222

83

1,999

3,577

Total revenues

-

-

-

-

244

632

1,710

3,459

3,499

8,547

10,816

Costs and expenses:
Cost of revenues

-

-

-

-

-

1,558

1,051

-

-

-

-

Cost of commercial product revenues

-

-

-

-

3,004

-

-

3,850

5,434

7,732

9,102

Cost of government contract revenues

-

-

-

-

-

-

-

165

79

1,180

2,552

Research and development

2,353

2,352

2,644

2,784

4,125

5,992

6,073

-

-

-

-

Research and development

-

-

-

-

-

-

-

5,030

5,325

5,067

4,399

Selling, general and administrative

3,918

3,972

4,062

5,146

5,838

5,389

5,068

5,440

6,322

6,684

6,925

Total costs and expenses

9,833

9,779

10,109

11,374

12,967

12,939

12,192

14,485

17,160

20,663

22,978

Loss from operations

-9,288

-8,223

-9,663

-11,243

-12,723

-12,307

-10,482

-11,026

-13,661

-12,116

-12,162

Other Income and Expense:
Gain from investment in Resonant LLC joint venture

-

-

-

-

-

3,142

-238

-

-

-

-

Adjustments to fair value of warrant derivatives

-

52

99

183

4,852

480

-1,551

-

-

-

-

Adjustment to warrant exercise price

-

24

-

66

537

-

-

-

-

-

-

Other income

59

64

37

10

13

434

140

-

-

-

-

Other expense

-

-

-

-

207

-

42

-

-

-

-

Impairment of asset for, and noncontrolling interest in joint venture

-

-

-

-

-

-

-

-

-

-

638

Adjustments to fair value of derivatives

-

-

-

-

-

-

-

-

-

171

-171

Interest income

-

-

-

-

-

-

-

6

22

6

24

Other income

-

-

-

-

-

-

-

92

269

-

-

Interest expense

-

-

-

-

-

-

-

-

13

29

32

Net loss

-9,229

-8,131

-9,527

-11,116

-8,602

-8,251

-12,173

-10,928

-13,383

-11,968

-12,979

Basic and diluted net loss per common share

-1.23

-4.03

-9.06

-35.31

-6.55

-9.67

-1.71

-3.34

-5.05

-0.51

-0.65

Basic and diluted weighted average number of common shares outstanding

7,486

2,016

1,052

314

1,313

852

7,123

-

-

23,344

-

Basic and diluted weighted average number of common shares outstanding

-

-

-

-

-

-

-

3,269

2,652

-

-

Weighted average number of common shares outstanding

-

-

-

-

-

-

-

-

-

-

19,842

Commercial Product Revenues [Member]
Total revenues

5

-

11

131

-

-

-

-

-

-

-

Cost of revenues

3,259

2,245

3,072

3,444

-

-

-

-

-

-

-

Government Contract Revenues [Member]
Total revenues

540

1,556

435

-

-

-

-

-

-

-

-

Cost of revenues

303

1,210

331

-

-

-

-

-

-

-

-